Health
AstraZeneca-Oxford manufacturing error clouds vaccine study results – Nikkei Asia
University says some vials in the trial didn’t have right concentration of vaccine
LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.
A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected.
In a surprise, the group of volunteers that got a lower dose seemed…
-
Business16 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News20 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’